RVMD: Nilai perusahaan marang bathi resik Revolution Medicines Inc

Revolution Medicines Inc - logo grafis emiten RVMD

The median P/E of Revolution Medicines (RVMD) reflects the business valuation trend, where -20.00 represents the current metric level. Diversifying research across various oncology drugs minimizes the risks associated with individual test failures. The development of unique inhibitors will ensure monopoly pricing power in the future. Despite a reliance on external financing, the value of the company's scientific developments remains stable regardless of market cycles.

Koefisien rega marang bathi: Revolution Medicines (RVMD) kanggo 04.07.2022 - 16.11.2026

Rincian metrik komprehensif lan analitis Revolution Medicines Inc (RVMD)

- rega saham lan prakiraan rega para ahli:
Analisis komprehensif perusahaan:Revolution Medicines, Inc. - RVMD
Barang unggulan Revolution Medicines, Inc.

Revolution Medicines specializes in developing long-term targeted oncology solutions, which ensures a stable revenue stream due to the chronic nature of these diseases. By analyzing the company's current P/E ratio, an investor assesses the relationship between the business's market value and its annual earnings, allowing them to determine the extent of the asset's overvaluation and identify liquidity risks in a timely manner during share price volatility.

Pesaing wigati

ONC: Nilai perusahaan marang bathi resik|Koefisien rega marang bathi HALO (Halozyme Inc.)|AAPG (Ascentage) - Nilai perusahaan marang bathi resik|Pangali P/E CGON (cgoncology.com)|URGN - Koefisien rega marang bathi|BCAX: Koefisien rega marang bathi|PSNL - Pangali P/E|Erasca Corp (ERAS) - Rasio rega marang bathi|Delcath - Nilai perusahaan marang bathi resik|YMAB (Y-mAbs Therapeutics Inc) - Pangali P/E|Kapitalisasi marang bathi Aura Biosciences, Inc. AURA|Pangali P/E CADL|Pangali P/E Accuray (ARAY)|Rasio rega marang bathi SELLAS Life Sciences Group Inc. SLS|ACTU - Koefisien rega marang bathi|CTOR: Koefisien rega marang bathi|Nilai perusahaan marang bathi resik HURA (TuHURA Biosciences Inc.)|TARA (Protara Therapeutics) - Koefisien rega marang bathi|Kapitalisasi marang bathi Fate Therapeutics Corp (FATE)|Koefisien rega marang bathi WHWK|Pangali rega marang bathi TCRX (TScan Therapeutics, Inc.)|Pangali P/E CSBR|XBIT - Kapitalisasi marang bathi|CEL-SCI Corporation - Koefisien rega marang bathi|Nilai perusahaan marang bathi resik OSTX|radiopharmtheranostics.com - Pangali P/E|ARTV: Rasio rega marang bathi|ANL (adlainortye.com) - Koefisien rega marang bathi|VERU - Periode bali modal bisnis|TPST (Tempest Therapeutics, Inc.) - Pangali P/E|Pangali P/E xiliotx.com|Rasio rega marang bathi Enochian BioSciences (RENB)|Rasio rega marang bathi MURA (Mural Oncology PLC)|Rasio rega marang bathi Kairos Pharma Ltd KAPA|Pangali P/E OnKure Therapeutics Inc OKUR|CytoMed Therapeutics - Pangali P/E|Periode bali modal bisnis Curis CRIS|APLM: Pangali P/E|Koefisien rega marang bathi Tharimmune, Inc.|ADVB (Advanced Biomed) - Pangali P/E|Genprex - Kapitalisasi marang bathi resik|Rasio rega marang bathi calidibio.com (CLDI)|SBFM (Sunshine Biopharma Inc.) - Nilai perusahaan marang bathi resik|Pangali P/E XBIO (Xenetic Biosciences)|Salarius Pharmaceuticals (SLRX) - Kapitalisasi marang bathi|PPBT: Koefisien rega marang bathi|Nilai perusahaan marang bathi resik AONC (American Oncology Network, Inc.)|BeOne Medicines (BGNE) - Rasio rega marang bathi|Checkpoint Therapeutics, Inc (CKPT) - Pangali P/E|Rasio rega marang bathi Elevation Oncology, Inc.|ICAD: Nilai perusahaan marang bathi resik|Rasio rega marang bathi ikenaoncology.com (IKNA)|Rasio rega marang bathi NTBL (Notable Labs, Ltd.)|Pangali P/E VIRX (viracta.com)|MOR - Koefisien rega marang bathi|NAYA - Rasio rega marang bathi|Kapitalisasi marang bathi resik AAPGV